4th ACE CLINICAL TRIALS SUMMIT
2nd - 3rd April, 2025
WEDNESDAY-THURSDAY
The Insurance Hall, London, UK
About 4th ACTS
4th ACE CLINICAL TRIALS SUMMIT, 2025 provides a platform to discuss main trends, current challenges and futuristic advancements in clinical trials and clinical research occurring in pharma world. Senior-level experts from top pharma companies will be sharing their professional insights and experiences related to the new clinical trials formats, rare disease trials and their best approaches, patient safety perspectives, building and implementing data-driven site selection approaches, wearables clinical trials, risks and benefits from a scientific and an operational perspective and much more. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by making new business alliances. Through case studies, panel & roundtable breakout discussions and an active exhibit hall, the summit delivers the real-world experiences and best practices needed to optimize clinical trial innovation, planning and management. It gives us a great pleasure in welcoming you to the 4th ACE CLINICAL TRIALS SUMMIT, 2025. We look forward to seeing you there.

Why Attend





Solutions at ACTS
🔷 Bio Statistics
🔷 Clinical Monitoring
🔷 Clinical Research
🔷 Contract Research Organization
🔷 Device testing
🔷 Global Clinical Research & Development
🔷 Imaging Tools
🔷 Logistics & Materials Handling
🔷 Medical Writing & Simulation
🔷 Quality Assurance
🔷 Central Laboratory Services
🔷 Clinical Operations
🔷 Clinical Trial Management
🔷 Development Operations
🔷 eClinical Technologies
🔷 Global Project & site Management
🔷 Investigator Site Services
🔷 Medical Testing
🔷 Patient recruitment & Retention
🔷 Regulatory Affairs
🔷 Clinical Data Management
🔷 Clinical Program Management
🔷 Comparator Sourcing & Drug Procurement    Services
🔷 Electronic Data Capture
🔷 Health Economics & Outcomes Research
🔷 Medical Translation
🔷 Pharmacovigilance & Drug Safety
🔷 Statistical Programming
Who Will Attend
🔷 Medical Affairs Director
🔷 Clinical Site Managers
🔷 Clinical Trials Managers
🔷 Budgeting & Outsourcing Directors
🔷 Clinical Trial Management Heads
🔷 Data Management Heads
🔷 Clinical Trial R&D Heads
🔷 Clinical Operations Heads
🔷 Clinical Statistics Directors
🔷 Clinical Trial Outsourcing Heads
🔷 Bio Statisticians
🔷 Clinical Trial Management Directors
🔷 Clinical Development Directors
🔷 Medical Directors
🔷 Clinical Country Leeds
🔷 Clinical Project Managers
🔷 Clinical Operations & Development
   Directors
🔷 Site Management Directors
🔷 Risk Based Monitoring Directors
🔷 Clinical Informatics Directors
ACTS Thought Leaders

IAN HODGSON
Head of Operations |
Corbus Pharmaceuticals Inc

AMELIA HURSEY
Â
Research Manager |
Parkinson’s Europe

Arun Ravindran
Benefit Risk Lead |
UCB

Meelis Lootus
CEO |
 Tehistark

NINA SKORYTCHENKO
CEO |
Avenna Ltd

NORA ROESCH
Global Medical Director |
Sanofi

Pedro Coelho
CEO
| Biorce

Joseph Kim
Chief Strategy Officer
| Proofpilot

Julie McCullough
Industry Engagement Manager | Public Health Agency

Brone Lenkeviciute-Vasiliauskiene
BDM | Valos Srl

Salomea Guchmazashvili
Researcher | World Health Organization

Helen Johansen Blanco
Chief Operating Officer (COO) | Node Pharma AS

Lorenzo Ciappina
Director Medical Information and Medical communication Eu/REALM | Incyte International

Stefan Ibing
Head Legal International Commercial | Apellis International GmbH

Carl Bjartmar
Chief Medical Officer | Augustine Therapeutics

Dimitris Zampatis
Global Program Safety Lead |
Sandoz

Martina Barcaroli
Global Senior Study Manager |
Angelini

Rasmus Hjorth
Head of Communication |
James Lind Care

Charlotte Smerdon
Senior Director Clinical Operations | PureSpring Therapeutics

Eamonn McArdle
Lead Clinical Supply Chain Pharmacist | Allergy Therapeutics

NAJY ALSAYED
Global Therapeutic
Area Head | Menarini Group

Aldir Medeiros
Filho
Clinical Data Scientist

Dr. Joan Dsouza
Pharmacovigilance Consultant/ Auditor

Sophie Wintrich
Committee Member |
ALAN

Hannah Thurgur
Clinical Trial Manager |
Imperial College London

Marlene Vincent
Head of Patient Advocacy | Intercept Therapeutics

NADILKA HETTIARACHCHIGE
Global Medical Director |
Ascelia Pharma AB

Michael Watts
Medical Doctor | University Hospitals Derby and Burton NHS Trust

Amer Alghabban
R&D Quality Regulatory Authority Inspection Management | Bristol Myers Squibb (BMS)

Divya Chadha Manek
Director, Clinical Operations | Eyebiotech Limited

Mustafa Ghafouri
Senior Data Scientist |
Population Health Partners

Mariusz Olejniczak
CEO |
WPD Pharmaceuticals Sp. z o.o.
Attendee Breakdown
Attendee Demographics
Agenda
🔷 08:45 – 09:00 Chairman’s Welcome Remarks
🔷 09:00 – 09:30 Presentation no.1:
Shaping the Future of Clinical Trial: What’s Coming Up Next in Digital Medicine and Innovative Technology
- Creating a clinical trial model that is able to withstand global disruption
- Looking at virtual aspects of clinical trials that should be fully implemented crisis or no crisis
- Investing for success – what lessons has this crisis taught us and how will we implement this moving forward?
Buyers 2025 Pharma / Biotech


Our Sponsors









Our Partners
Venue - The Insurance Hall, London, UK
Â
The Insurance Hall has been the home of the UK Insurance sector for over 80 years. It is a prestigious and impressive event venue steeped in history, heritage and architectural significance, a hidden gem in one of City of London’s most decorated and prestigious buildings.
A Grade II listed building formally opened by His Majesty King George V in 1934, The Insurance Hall offers exceptional and flexible event spaces for conferences, receptions, AGMs, business breakfasts, meetings, lunches and dinners for up to 300 delegates.

SPONSORSHIP OPPORTUNITIES
If you wish to inquire about sponsorship prospects, kindly reach out to:

SPEAKER / DELEGATE OPPORTUNITIES
If you wish to inquire about speaking opportunities, and to book attendee pass, kindly reach out to:
